Tag: Immunotherapy
Immune Checkpoint Inhibitor Efficacy Varies by Sex
Magnitude of benefit of immune checkpoint inhibitors sex-dependent for patients with advanced cancers
Uveal Effusion Reported After Initiation of Anti-PD-1, -PD-L1
Case series IDs three patients who developed uveal effusion within one to two months of initiating tx
Chemo, Immunotherapy Feasible in Metastatic Bladder Cancer
One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab
Grass Peptide Immunotherapy Cuts Seasonal Allergy Symptoms
Subcutaneous injections administered over three-week period before grass pollen season
Peanut Patch Found Safe, Effective for Treating Allergies
250-μg patch produces significant treatment response compared with placebo after 12 months
Immunosuppressant Response Predicts Aplastic Anemia Survival
Overall survival superior in therapy responders; shorter relapse-free survival with partial response
Peptide Immunotx Well Tolerated in New-Onset Type 1 Diabetes
No decline in C-peptide with peptide immunotherapy; no change in insulin use over 12 months
Cost-Effectiveness of Allergen Immunotherapy Evaluated
AIT may be cost-effective for allergic rhinitis and in high-risk groups for venom allergy
Immunotherapy Efficacy Up With Gal-1/SIT Co-Administration
Suppressed allergic responses in mouse intestine with Gal-1, allergen-specific immunotherapy
ASCO: CAR T-Cell Therapy Promising in Multiple Myeloma
Findings from trial of chimeric antigen receptor T cells targeting B-cell maturation protein
